ALACT.PA

Acticor Biotech SAS [ALACT.PA] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

ALACT.PA Stock Summary

Top 10 Correlated ETFs

ALACT.PA


Top 10 Correlated Stocks

ALACT.PA


In the News

ALACT.PA Financial details

Company Rating
Buy
Market Cap
35.78M
Income
0
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
29
Optionable
No
Shortable
Yes
Earnings
26 Oct 2023
P/E
-1.83
Forward P/E
-
PEG
-
P/S
-
P/B
-13.54
P/C
-
P/FCF
-3.12
Quick Ratio
0.98
Current Ratio
1.75
Debt / Equity
19.15
LT Debt / Equity
11.8
-
-
EPS (TTM)
0
EPS next Y
-
EPS next Q
-
EPS this Y
-7.06%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
22.62%
Revenue last 5Y
-100%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-25%
SMA50
-40%
SMA100
-40%
Inst Own
-
Inst Trans
-
ROA
-129%
ROE
-379%
ROC
-2.42%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
13.33M
Shs Float
5.71M
-
-
-
-
Target Price
-
52W Range
2.72-11.0
52W High
-73.64%
52W Low
+45%
RSI
31
Rel Volume
0.66
Avg Volume
3.49K
Volume
2.3K
Perf Week
2.84%
Perf Month
-25.45%
Perf Quarter
-45.08%
Perf Half Y
-48.03%
-
-
-
-
Beta
-0.367
-
-
Volatility
0.04%, 0.42%
Prev Close
0%
Price
2.9
Change
0%

ALACT.PA Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000
Net income per share
-0.57-0.48-0.73-1.7-1.58
Operating cash flow per share
-0.52-0.41-0.64-1.77-1.15
Free cash flow per share
-0.52-0.41-0.64-1.77-1.15
Cash per share
0.971.220.721.460.63
Book value per share
0.590.860.161.42-0.21
Tangible book value per share
0.590.790.11.42-0.28
Share holders equity per share
0.590.860.161.42-0.21
Interest debt per share
0.130.120.250.420.82
Market cap
74.35M74.35M74.35M35.63M74.45M
Enterprise value
65.36M62.6M69.32M26.99M75.72M
P/E ratio
-12.41-14.71-9.62-2.7-4.48
Price to sales ratio
1.49K0000
POCF ratio
-13.58-17.39-11.03-2.59-6.15
PFCF ratio
-13.44-17.32-10.94-2.59-6.15
P/B Ratio
11.928.2343.333.23-33.19
PTB ratio
11.928.2343.333.23-33.19
EV to sales
1.31K0000
Enterprise value over EBITDA
-11.52-13.42-9.33-2.27-5.04
EV to operating cash flow
-11.94-14.64-10.29-1.96-6.26
EV to free cash flow
-11.81-14.58-10.21-1.96-6.25
Earnings yield
-0.08-0.07-0.1-0.37-0.22
Free cash flow yield
-0.07-0.06-0.09-0.39-0.16
Debt to equity
0.190.131.490.25-3.51
Debt to assets
0.110.070.230.150.61
Net debt to EBITDA
1.582.520.680.73-0.08
Current ratio
2.712.81.594.161.75
Interest coverage
-37.15-58.68-95.9-19.98-19.74
Income quality
0.910.850.881.090.76
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
31.060000
Research and developement to revenue
81.840000
Intangibles to total assets
00.050.060.040.06
Capex to operating cash flow
0.0100.0100
Capex to revenue
-1.160000
Capex to depreciation
-0.37-0.03-0.38-0.14-0.07
Stock based compensation to revenue
0.680000
Graham number
2.753.041.647.352.75
ROIC
-0.78-0.48-1.74-0.9-2.82
Return on tangible assets
-0.53-0.34-0.75-0.77-1.36
Graham Net
0.480.62-0.160.58-0.81
Working capital
7.01M9.29M3.74M12.82M5.04M
Tangible asset value
6.24M8.32M1M10.31M-2.96M
Net current asset value
5.95M8.09M817K10.01M-3.45M
Invested capital
0.190.131.490.25-3.51
Average receivables
00000
Average payables
905.5K1.07M2.17M2.87M4.08M
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
00000
Inventory turnover
00000
ROE
-0.96-0.56-4.5-1.27.42
Capex per share
-0.010-0.0100

Quarterly Fundamentals Overview

Last date of statement is 2023-06-30 for Q2

Metric History 2021-06-302021-12-312022-06-302022-12-31 2023-06-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000
Net income per share
00000
Operating cash flow per share
00000
Free cash flow per share
00000
Cash per share
00000
Book value per share
00000
Tangible book value per share
00000
Share holders equity per share
00000
Interest debt per share
00000
Market cap
00000
Enterprise value
-4.21M-8.64M-2.31M1.26M-908K
P/E ratio
00000
Price to sales ratio
00000
POCF ratio
00000
PFCF ratio
00000
P/B Ratio
00000
PTB ratio
00000
EV to sales
00000
Enterprise value over EBITDA
00000
EV to operating cash flow
00000
EV to free cash flow
00000
Earnings yield
00000
Free cash flow yield
00000
Debt to equity
1.120.250.6-3.5119.15
Debt to assets
0.350.150.230.610.49
Net debt to EBITDA
00000
Current ratio
3.114.162.291.751.52
Interest coverage
00000
Income quality
00000
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
0.050.040.060.060.05
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
00000
ROIC
00000
Return on tangible assets
00000
Graham Net
00000
Working capital
8.35M12.82M5.77M5.04M4.43M
Tangible asset value
3.4M10.31M3.6M-2.96M-345K
Net current asset value
3.26M10.01M3.22M-3.45M-895K
Invested capital
1.120.250.6-3.5119.15
Average receivables
00000
Average payables
00000
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
00000
Inventory turnover
00000
ROE
00000
Capex per share
00000

ALACT.PA Frequently Asked Questions

What is Acticor Biotech SAS stock symbol ?

Acticor Biotech SAS is a FR stock and trading under the symbol ALACT.PA

What is Acticor Biotech SAS stock quote today ?

Acticor Biotech SAS stock price is $2.9 today.

Is Acticor Biotech SAS stock public?

Yes, Acticor Biotech SAS is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated Stocks
Similar Market Cap